TMCnet News
Organ-On-Chip Global Market 2018 - Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, Hrel, and Nortis Dominating the Industry - Research and MarketsThe "Organ-On-Chip Global Market 2018" report has been added to Research and Markets' offering. The global market for OOCs was valued at $20 million in 2016. It is expected to grow at a compound annual growth rate (CAGR) of 70% to reach $284 million by 2021. The small size of the market is mainly due to the fact that OOCs have not yet been fully commercialized. They are still in the research and development phase and are primarily being used by a limited number of end-users. The OOC market is expected to rise at this high CAGR due to an increase in the number of collaborative sales agreements between the pharmaceutical companies and university spin-offs and the entry of new advanced models of OOCs into the market. The anticipated launch of advanced organ-specific models and human-on-chip models is expected to further increase the growth rate of this market in future. OOC technology is still at an initial stae of research, development and commercialization. The players in the market are primarily university spinoffs involved in the commercialization of OOC prototypes developed in the universities. The key players include Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, Hrel and Nortis. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements. Currently OOCs are marketed primarily through sales agreements with end-users that involve collaboration of both parties in tailoring the OOCs to meet the end-user's requirements. Companies Mentioned:
Key Topics:
For more information about this report visit https://www.researchandmarkets.com/research/79z7sm/organonchip?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180105005519/en/ |
